268 related articles for article (PubMed ID: 34004600)
1. Prediction of the Risk of Alopecia Areata Progressing to Alopecia Totalis and Alopecia Universalis: Biomarker Development with Bioinformatics Analysis and Machine Learning.
Zhang T; Nie Y
Dermatology; 2022; 238(2):386-396. PubMed ID: 34004600
[TBL] [Abstract][Full Text] [Related]
2. A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study.
Zheng Y; Nie Y; Lu J; Yi H; Fu G
Front Med (Lausanne); 2023; 10():1189134. PubMed ID: 37359017
[TBL] [Abstract][Full Text] [Related]
3. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.
Jabbari A; Cerise JE; Chen JC; Mackay-Wiggan J; Duvic M; Price V; Hordinsky M; Norris D; Clynes R; Christiano AM
EBioMedicine; 2016 May; 7():240-7. PubMed ID: 27322477
[TBL] [Abstract][Full Text] [Related]
5. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
[TBL] [Abstract][Full Text] [Related]
6. Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning.
Xu W; Wei D; Song X
Sci Rep; 2024 Feb; 14(1):3800. PubMed ID: 38360836
[TBL] [Abstract][Full Text] [Related]
7. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity.
Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S
Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis.
Colombe BW; Lou CD; Price VH
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):216-9. PubMed ID: 10674369
[TBL] [Abstract][Full Text] [Related]
9. Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.
Uzuncakmak TK; Engin B; Serdaroglu S; Tuzun Y
Skin Appendage Disord; 2021 Jan; 7(1):8-12. PubMed ID: 33614711
[TBL] [Abstract][Full Text] [Related]
10. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
Mostaghimi A; Gandhi K; Done N; Ray M; Gao W; Carley C; Wang T; Swallow E; Sikirica V
J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790
[No Abstract] [Full Text] [Related]
11. Treatment Patterns for Alopecia Areata in the US.
Lee H; Huang KP; Mostaghimi A; Choudhry NK
JAMA Dermatol; 2023 Nov; 159(11):1253-1257. PubMed ID: 37728940
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database.
George P; Jagun O; Liu Q; Wentworth C; Napatalung L; Wolk R; Anway S; Zwillich SH
J Dermatol; 2023 Sep; 50(9):1121-1128. PubMed ID: 37291688
[TBL] [Abstract][Full Text] [Related]
13. A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata.
Deeb M; Beach RA
J Cutan Med Surg; 2017; 21(6):562-563. PubMed ID: 28635319
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma in alopecia areata.
Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
[TBL] [Abstract][Full Text] [Related]
15. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
Strazzulla LC; Wang EHC; Avila L; Lo Sicco K; Brinster N; Christiano AM; Shapiro J
J Am Acad Dermatol; 2018 Jan; 78(1):1-12. PubMed ID: 29241771
[TBL] [Abstract][Full Text] [Related]
16. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH; Gwillim E; Patel KR; Hua T; Rastogi S; Ibler E; Silverberg JI
J Am Acad Dermatol; 2020 Mar; 82(3):675-682. PubMed ID: 31437543
[TBL] [Abstract][Full Text] [Related]
18. CHAC1 as a novel biomarker for distinguishing alopecia from other dermatological diseases and determining its severity.
Karami H; Nomiri S; Ghasemigol M; Mehrvarzian N; Derakhshani A; Fereidouni M; Mirimoghaddam M; Safarpour H
IET Syst Biol; 2022 Sep; 16(5):173-185. PubMed ID: 35983595
[TBL] [Abstract][Full Text] [Related]
19. Construction of regulatory network for alopecia areata progression and identification of immune monitoring genes based on multiple machine-learning algorithms.
Xiong J; Chen G; Liu Z; Wu X; Xu S; Xiong J; Ji S; Wu M
Precis Clin Med; 2023 Jun; 6(2):pbad009. PubMed ID: 37333624
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
